Immunoadsorption study Mainz in adults with post-COVID syndrome (IAMPOCO)—a single-blinded sham-controlled crossover trial to evaluate the effect of immunoadsorption on post-COVID syndrome

Abstract Background Post-COVID syndrome (PCS) affects up to 43% of all SARS-CoV-2-infected persons and describes ongoing symptoms months after the acute infection. Despite the large number of affected people, there is still very little evidence about therapeutic options. Some studies suggest at leas...

Full description

Saved in:
Bibliographic Details
Main Authors: Marco Stortz, Pascal Klimpke, Andreas Kommer, Philipp Gründer, Livia Steenken, Christian Dresel, Daniel Kraus, Irene Schmidtmann, Arndt Weinmann, Julia Weinmann-Menke
Format: Article
Language:English
Published: BMC 2025-04-01
Series:Trials
Subjects:
Online Access:https://doi.org/10.1186/s13063-025-08825-7
Tags: Add Tag
No Tags, Be the first to tag this record!